Immunotherapy News and Research

RSS

Immunotherapy is the concept of using the immune system to treat disease, for example, developing a vaccine against cancer. Immunotherapy may also refer to the therapy of diseases caused by the immune system, allergies for example.

Kobe University Unveils Mass-Producible Off-the-Shelf Cancer Fighters

Off-the-shelf and mass-producible immune cells fight solid human tumors engrafted into mice. The Kobe University development is a significant contribution towards faster and cheaper cancer immunotherapy.

24 Jul 2026

Artificially Recreating C3 Effects Overcomes Resistance in Hard-to-Treat Tumors

An ancient molecule that existed long before the blood circulation system evolved, has been found to support cancer immunotherapy. Researchers at Nagoya University in Japan found that complement C3 protein acts inside tumors to prevent the accumulation of immunosuppressive cells, but only when produced inside the tumor.

23 Jul 2026

Gut Bacteria Metabolites Successfully Boost Immune Response to Melanoma Tumors

A new study from a team including University of Nebraska–Lincoln researchers is the first to show metabolites produced by certain bacteria in the gut can positively impact the body's immune response to cancer.

15 Jul 2026

Antibody-Based Strategy Makes Stem Cell Transplants Safer

Stem cell transplantation (also called bone marrow transplantation) and gene therapy are among the most powerful curative approaches for blood diseases such as sickle cell disease, b-thalassemia, immune deficiencies, and some blood cancers.

9 Jul 2026

New ATTACH System Overcomes Key Bottleneck in Personalized Immunotherapy Development

A new platform developed by researchers at The University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells, even without knowing which tumor targets are recognized by the immune cells.

9 Jul 2026

Gut Microbiome Signatures Correlate With Clinical Efficacy in Immunotherapy Outcomes

Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to evade immune surveillance and resist conventional therapies.

9 Jul 2026

Gut Bacteria Actively Manage Vitamin A Delivery for T Cell Maturation

Scientists at UT Southwestern Medical Center have discovered that gut bacteria help regulate the development of the body's immune system by directing the movement of vitamin A through a previously unrecognized cellular network.

8 Jul 2026

Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

Bio-Techne Corporation, a global provider of life science tools, reagents, and diagnostic products, today announced the launch of new additions to its R&D Systems™ AI-Engineered Designer Protein portfolio, designed to improve reproducibility and performance across advanced cell culture and cell therapy development workflows.

From Bio-Techne 8 Jul 2026

Study: Genetically Engineered CAR T Cells Suppress the Immune System’s Response to Allergen

Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the immune system's response against leukemias and other cancers.

7 Jul 2026

New Research Maps Gut Microbiome Impact on Liver Cancer Immunotherapy Resistance

Immune checkpoint blockade (ICB) has reshaped the treatment landscape for advanced hepatocellular carcinoma (HCC), offering new hope where few options existed.

3 Jul 2026

Research Links Bifidobacterium animalis Metabolites to Improved Anti-Tumor T Cell Immunity

Immune checkpoint inhibitors like anti-PD-1 have transformed melanoma treatment, yet more than half of patients fail to respond or eventually develop resistance. The tumor microenvironment and the gut microbiome are increasingly recognized as critical determinants of immunotherapy outcomes.

2 Jul 2026

Cancer Cells Hijack Macrophage Metabolism to Create an Immunosuppressive Tumor Microenvironment

Tumor-associated macrophages (TAMs) are among the most abundant immune cells in the tumor microenvironment. However, instead of attacking cancer cells, they are typically co-opted to support tumor growth, metastasis, and therapeutic resistance.

2 Jul 2026

Advanced Bioinformatics Models Reveal Bacterial Function in Colon Cancer Patients

Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome's composition.

29 Jun 2026

New Progenitor Cell Platform Offers Scalable Source for Immunotherapy

In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages.

22 Jun 2026

Advanced Bladder Cancer Spatial Mapping Identifies Diverse Cellular Tumor States

Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder cancer, revealing how tumor cell states, immune environments and therapeutic vulnerabilities are organized within tumors.

19 Jun 2026

Mouse Models Show Neutrophils Decrease Success Rates of Cancer Immunotherapy

A type of white blood cell in the immune system, known as neutrophils, can make cancer immunotherapy less effective.

16 Jun 2026

Peking University Researchers Map High Dimensional Cellular Networks in Tumors

A comprehensive review led by Associate Researcher Linnan Zhu and Academician Zemin Zhang at Biomedical Pioneering Innovation Center (BIOPIC), Peking University, China, and Chongqing Medical University, China, was published in Volume 2, article number 27 of the journal Immunity & Inflammation on June 05, 2026.

13 Jun 2026

Immunotherapy News and Research

Kobe University Unveils Mass-Producible Off-the-Shelf Cancer Fighters

Artificially Recreating C3 Effects Overcomes Resistance in Hard-to-Treat Tumors

Gut Bacteria Metabolites Successfully Boost Immune Response to Melanoma Tumors

Antibody-Based Strategy Makes Stem Cell Transplants Safer

New ATTACH System Overcomes Key Bottleneck in Personalized Immunotherapy Development

Gut Microbiome Signatures Correlate With Clinical Efficacy in Immunotherapy Outcomes

Gut Bacteria Actively Manage Vitamin A Delivery for T Cell Maturation

Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

Study: Genetically Engineered CAR T Cells Suppress the Immune System’s Response to Allergen

New Research Maps Gut Microbiome Impact on Liver Cancer Immunotherapy Resistance

Research Links Bifidobacterium animalis Metabolites to Improved Anti-Tumor T Cell Immunity

Cancer Cells Hijack Macrophage Metabolism to Create an Immunosuppressive Tumor Microenvironment

Advanced Bioinformatics Models Reveal Bacterial Function in Colon Cancer Patients

New Progenitor Cell Platform Offers Scalable Source for Immunotherapy

Advanced Bladder Cancer Spatial Mapping Identifies Diverse Cellular Tumor States

Mouse Models Show Neutrophils Decrease Success Rates of Cancer Immunotherapy

Peking University Researchers Map High Dimensional Cellular Networks in Tumors

New Cell Therapy Modifies Natural Killer Cells Against Cancer

Coffee Can Now Serve as a Biological Switch for Medicines

Creatine Linked to Cancer-Fighting Dendritic Cell Function

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

RecentIndustryFocuses

Cosmetic Formulation and Manufacturing

Selecting a Benchtop Fluorescence Microscope: Key Considerations for Your Lab

Biopharmaceuticals

Precision, Pricing and Progress in 2025: A Year That Shaped Life Science

Latest in Genomics